List of Excipients in API DEXLANSOPRAZOLE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DEXLANSOPRAZOLE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | ALUMINUM OXIDE | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | CARRAGEENAN | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | FD&C BLUE NO. 2 | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DEXLANSOPRAZOLE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | CARRAGEENAN |
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B |
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | FD&C BLUE NO. 2 |
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | FERROSOFERRIC OXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for DEXLANSOPRAZOLE
Excipient focus: ACID YELLOW 23
DEXLANSOPRAZOLE drug variants containing ACID YELLOW 23
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ACID YELLOW 23
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
DEXLANSOPRAZOLE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
DEXLANSOPRAZOLE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: BLUE 1
DEXLANSOPRAZOLE drug variants containing BLUE 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing BLUE 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
DEXLANSOPRAZOLE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing CALCIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing CALCIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
DEXLANSOPRAZOLE drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
DEXLANSOPRAZOLE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| Alembic Pharmaceuticals Inc | dexlansoprazole | 62332-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
DEXLANSOPRAZOLE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
DEXLANSOPRAZOLE drug variants containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
DEXLANSOPRAZOLE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
DEXLANSOPRAZOLE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| Alembic Pharmaceuticals Inc | dexlansoprazole | 62332-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
DEXLANSOPRAZOLE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
DEXLANSOPRAZOLE drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
DEXLANSOPRAZOLE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
DEXLANSOPRAZOLE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
DEXLANSOPRAZOLE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| Alembic Pharmaceuticals Inc | dexlansoprazole | 62332-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
DEXLANSOPRAZOLE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE
DEXLANSOPRAZOLE drug variants containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
DEXLANSOPRAZOLE drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| Physicians Total Care Inc | dexlansoprazole | 54868-6152 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL METHYLCELLULOSE
DEXLANSOPRAZOLE drug variants containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Physicians Total Care Inc | dexlansoprazole | 54868-6152 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
DEXLANSOPRAZOLE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: LAURYL SULFATE
DEXLANSOPRAZOLE drug variants containing LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CARBONATE
DEXLANSOPRAZOLE drug variants containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
DEXLANSOPRAZOLE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-20 SORBITAN OLEATE
DEXLANSOPRAZOLE drug variants containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
DEXLANSOPRAZOLE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
DEXLANSOPRAZOLE drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| Alembic Pharmaceuticals Inc | dexlansoprazole | 62332-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
DEXLANSOPRAZOLE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
DEXLANSOPRAZOLE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: SAND
DEXLANSOPRAZOLE drug variants containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
DEXLANSOPRAZOLE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
DEXLANSOPRAZOLE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
DEXLANSOPRAZOLE drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| Alembic Pharmaceuticals Inc | dexlansoprazole | 62332-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
DEXLANSOPRAZOLE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| A-S Medication Solutions | dexlansoprazole | 50090-4374 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-5944 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
DEXLANSOPRAZOLE drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
DEXLANSOPRAZOLE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DEXLANSOPRAZOLE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
DEXLANSOPRAZOLE drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: YELLOW 6
DEXLANSOPRAZOLE drug variants containing YELLOW 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing YELLOW 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZEA MAYS
DEXLANSOPRAZOLE drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dexlansoprazole | 50090-7451 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| Alembic Pharmaceuticals Limited | dexlansoprazole | 46708-823 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
